Clinical significance of immunohistochemically-identified lymphatic and/or blood vessel tumor invasion in gastric cancer

Journal of Surgical Research

Volumn 162, Issue 2, 2010, Pages 177-183

  Kim, Jong Han ^a   Park, Sung Soo ^a   Park, Seong Heum ^a   Kim, Seung Joo ^a   Mok, Young Jae ^a   Kim, Chong Suk ^a   Lee, Ju Han ^a   Kim, Young Sik ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Gastric cancer; Immunohistochemistry; Lymphatic invasion; Vascular invasion

Indexed keywords

CD31 ANTIGEN; EOSIN; HEMATOXYLIN; MONOCLONAL ANTIBODY D2-40;

ADULT; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHANGIOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH CANCER; TREATMENT OUTCOME; TUMOR VOLUME; VASCULAR TUMOR;

EID: 77955980556     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.07.015     Document Type: Article

References (28)

1. Yoo CH, Noh SH, Shin DW, et al. Recurrence following curative resection for gastric carcinoma. Br J Surg 2000;87:236.
2. Marrelli D, De Stefano A, de Manzoni G, et al. Prediction of recurrence after radical surgery for gastric cancer: A scoring system obtained from a prospective multicenter study. Ann Surg 2005;241:247.
3. Kim JP, Lee JH, Kim SJ, et al. Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer. Gastric Cancer 1998;1:125.
4. Siewert JR, Bottcher K, Roder JD, et al. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br J Surg 1993;80:1015.
5. Liang P, Nakada I, Hong JW, et al. Prognostic significance of immunohistochemically detected blood and lymphatic vessel invasion in colorectal carcinoma: Its impact on prognosis. Ann Surg Oncol 2007;14:470.
6. Brucher BL, Stein HJ, Werner M, et al. Lymphatic vessel invasion is an independent prognostic factor in patients with a primary resected tumor with esophageal squamous cell carcinoma. Cancer 2001;92:2228.
7. Schmid K, Birner P, Gravenhorst V, et al. Prognostic value of lymphatic and blood vessel invasion in neuroendocrine tumors of the lung. Am J Surg Pathol 2005;29:324.
8. del Casar JM, Corte MD, Alvarez A, et al. Lymphatic and/or blood vessel invasion in gastric cancer: Relationship with clinicopathological parameters, biological factors and prognostic significance. J Cancer Res Clin Oncol 2008;134:153.
9. Yonemura Y, Endou Y, Tabachi K, et al. Evaluation of lymphatic invasion in primary gastric cancer by a new monoclonal antibody, D2-40. Hum Pathol 2006;37:1193.
10. Arigami T, Natsugoe S, Uenosono Y, et al. Lymphatic invasion using D2-40 monoclonal antibody and its relationship to lymph node micrometastasis in pN0 gastric cancer. Br J Cancer 2005;93:688.
11. Dicken BJ, Graham K, Hamilton SM, et al. Lymphovascular invasion is associated with poor survival in gastric cancer: An application of gene-expression and tissue array techniques. Ann Surg 2006;243:64.
12. Maehara Y, Kabashima A, Koga T, et al. Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma. Surgery 2000;128:408.
13. Horak ER, Leek R, Klenk N, et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992;340:1120.
14. Hyung WJ, Lee JH, Choi SH, et al. Prognostic impact of lymphatic and/or blood vessel invasion in patients with nodenegative advanced gastric cancer. Ann Surg Oncol 2002;9:562.
15. Schoppmann SF, Bayer G, Aumayr K, et al. Prognostic value of lymph angiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg 2004;240:306.
16. Leu AJ, Berk DA, Lymboussaki A, et al. Absence of functional lymphatics within a murine sarcoma: A molecular and functional evaluation. Cancer Res 2000;60:4324.
17. Padera TP, Kadambi A, di Tomaso E, et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 2002;296:1883.
18. Setala LP, Kosma VM, Marin S, et al. Prognostic factors in gastric cancer: The value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration. Br J Cancer 1996;74:766.
19. Gabbert HE, Meier S, Gerharz CD, et al. Incidence and prognostic significance of vascular invasion in 529 gastric-cancer patients. Int J Cancer 1991;49:203.
20. Maehara Y, Oshiro T, Baba H, et al. Lymphatic invasion and potential for tumor growth and metastasis in patients with gastric cancer. Surgery 1995;117:380.
21. Noguchi Y. Blood vessel invasion in gastric carcinoma. Surgery 1990;107:140.
22. Marks A, Sutherland DR, Bailey D, et al. Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours. Br J Cancer 1999;80:569.
23. Kahn HJ, Marks A. A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 2002;82:1255.
24. Fogt F, Zimmerman RL, Ross HM, et al. Identification of lymphatic vessels in malignant, adenomatous and normal colonic mucosa using the novel immunostain D2-40. Oncol Rep 2004;11:47.
25. Sako A, Kitayama J, Ishikawa M, et al. Impact of immunohistochemically identified lymphatic invasion on nodal metastasis in early gastric cancer. Gastric Cancer 2006;9:295.
26. Sugarbaker PH. Peritonectomy procedures. Cancer Treat Res 1996;82:235.
27. Kim JH, Park JM, Jung CW, et al. The significances of lymph node micrometastasis and its correlation with E-cadherin expression in pT1-T3N0 gastric adenocarcinoma. J Surg Oncol 2008;97:125.
28. Yokota T, Kunii Y, Teshima S, et al. Significant prognostic factors in patients with early gastric cancer. Int Surg 2000;85:286.